Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.
Darshan A MehtaEric CohenMariem CharafeddineDaniel E CohenYanjun BaoYuri Sanchez GonzalezTram T TranPublished in: Infectious diseases and therapy (2017)
Abbvie Inc.